Bausch Health Cos Basic EPS 2010-2024 | BHC
Bausch Health Cos basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Bausch Health Cos Annual Basic EPS |
| 2023 |
$-1.62 |
| 2022 |
$-0.62 |
| 2021 |
$-2.64 |
| 2020 |
$-1.58 |
| 2019 |
$-5.08 |
| 2018 |
$-11.81 |
| 2017 |
$6.86 |
| 2016 |
$-6.94 |
| 2015 |
$-0.85 |
| 2014 |
$2.63 |
| 2013 |
$-2.70 |
| 2012 |
$-0.38 |
| 2011 |
$0.52 |
| 2010 |
$-1.06 |
| 2009 |
$1.11 |
| Bausch Health Cos Quarterly Basic EPS |
| 2024-09-30 |
$-0.23 |
| 2024-06-30 |
$0.03 |
| 2024-03-31 |
$-0.17 |
| 2023-12-31 |
$-0.11 |
| 2023-09-30 |
$-1.03 |
| 2023-06-30 |
$0.07 |
| 2023-03-31 |
$-0.55 |
| 2022-12-31 |
$-1.13 |
| 2022-09-30 |
$1.10 |
| 2022-06-30 |
$-0.40 |
| 2022-03-31 |
$-0.19 |
| 2021-12-31 |
$0.21 |
| 2021-09-30 |
$0.52 |
| 2021-06-30 |
$-1.66 |
| 2021-03-31 |
$-1.71 |
| 2020-12-31 |
$-0.43 |
| 2020-09-30 |
$0.20 |
| 2020-06-30 |
$-0.92 |
| 2020-03-31 |
$-0.43 |
| 2019-12-31 |
$-4.30 |
| 2019-09-30 |
$-0.14 |
| 2019-06-30 |
$-0.49 |
| 2019-03-31 |
$-0.15 |
| 2018-12-31 |
$-0.96 |
| 2018-09-30 |
$-1.00 |
| 2018-06-30 |
$-2.49 |
| 2018-03-31 |
$-7.36 |
| 2017-12-31 |
$1.46 |
| 2017-09-30 |
$3.71 |
| 2017-06-30 |
$-0.11 |
| 2017-03-31 |
$1.80 |
| 2016-12-31 |
$-1.49 |
| 2016-09-30 |
$-3.49 |
| 2016-06-30 |
$-0.88 |
| 2016-03-31 |
$-1.08 |
| 2015-12-31 |
$-1.13 |
| 2015-09-30 |
$0.14 |
| 2015-06-30 |
$-0.15 |
| 2015-03-31 |
$0.29 |
| 2014-12-31 |
$1.50 |
| 2014-09-30 |
$0.82 |
| 2014-06-30 |
$0.38 |
| 2014-03-31 |
$-0.07 |
| 2013-12-31 |
$0.27 |
| 2013-09-30 |
$-2.92 |
| 2013-06-30 |
$0.04 |
| 2013-03-31 |
$-0.09 |
| 2012-12-31 |
$-0.30 |
| 2012-09-30 |
$0.03 |
| 2012-06-30 |
$-0.07 |
| 2012-03-31 |
$-0.04 |
| 2011-12-31 |
$0.18 |
| 2011-09-30 |
$0.13 |
| 2011-06-30 |
$0.19 |
| 2011-03-31 |
$0.02 |
| 2010-12-31 |
$0.02 |
| 2010-09-30 |
$-1.27 |
| 2010-06-30 |
$0.21 |
| 2010-03-31 |
$-0.02 |
| 2009-12-31 |
$0.46 |
| 2009-09-30 |
$0.25 |
| 2009-06-30 |
$0.15 |
| 2009-03-31 |
$0.25 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.358B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
